292 related articles for article (PubMed ID: 16509932)
41. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
[No Abstract] [Full Text] [Related]
42. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
[TBL] [Abstract][Full Text] [Related]
43. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
Mesquita MM; Pestana A; Mota A
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
[No Abstract] [Full Text] [Related]
44. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
[TBL] [Abstract][Full Text] [Related]
45. Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.
Thierry A; Dreyfus B; Bridoux F; Abou Ayache R; Milin S; Guilhot F; Touchard G
Nephrol Dial Transplant; 2007 Jun; 22(6):1791-2. PubMed ID: 17308316
[No Abstract] [Full Text] [Related]
46. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
Bren A; Kandus A; Ferluga D
Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
[No Abstract] [Full Text] [Related]
47. Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea.
Shammas F; Meyer P; Heikkila R; Apeland T; Gøransson L; Berland J; Kjellevold K
Acta Haematol; 1997; 97(3):184-6. PubMed ID: 9066715
[TBL] [Abstract][Full Text] [Related]
48. A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of action.
Smetana K; Jirásková I; Klamová H
Neoplasma; 1999; 46(5):295-8. PubMed ID: 10665845
[TBL] [Abstract][Full Text] [Related]
49. Hydroxyurea induced leg ulcers.
Abhyankar D; Shende C; Saikia T; Advani SH
J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
[TBL] [Abstract][Full Text] [Related]
50. Interferon alfa-associated anterior ischemic optic neuropathy.
Fraunfelder FW; Fraunfelder FT
Ophthalmology; 2011 Feb; 118(2):408-11.e1-2. PubMed ID: 20630599
[TBL] [Abstract][Full Text] [Related]
51. [Development of cyroglobulinemia and polyneuropathy in a chronic myeloid leukemia patient during interferon-alpha treatment].
Uoshima N; Akaogi T; Hayashi H; Kobayashi Y; Kondo M
Rinsho Ketsueki; 1999 Apr; 40(4):324-9. PubMed ID: 10355142
[TBL] [Abstract][Full Text] [Related]
52. Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate.
Alimena G; Breccia M; Luciano L; Quarantelli F; Diverio D; Izzo B; De Angelis B; Mancini M; Latagliata R; Carmosino I; Nanni M; Picardi M; Rotoli B; Mandelli F; Pane F
Leuk Res; 2008 Feb; 32(2):255-61. PubMed ID: 17692911
[TBL] [Abstract][Full Text] [Related]
53. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
Arimura K; Arima N; Ohtsubo H; Matsushita K; Kukita T; Ayukawa T; Kuroki T; Tei C
Acta Haematol; 2004; 112(4):217-8. PubMed ID: 15564735
[TBL] [Abstract][Full Text] [Related]
54. [Chronic myeloid leukemia in the 21st century: biology and treatment].
Chávez-González MA; Ayala-Sánchez M; Mayani H
Rev Invest Clin; 2009; 61(3):221-32. PubMed ID: 19736811
[TBL] [Abstract][Full Text] [Related]
55. Does interferon-a exert an anti-leukemic effect by enhancing cell mediated immunity in chronic myeloid leukemia?
Muretto P; Tomassoni S; Staccioli MP; Tabellini L; D'Adamo F; Delfini C
Haematologica; 2000 Feb; 85(2):212-3. PubMed ID: 10681734
[No Abstract] [Full Text] [Related]
56. Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia.
Zaucha JM; Wyrowinska E; Prejzner W; Calbecka M; Hellmann A
Clin Lab Haematol; 2006 Jun; 28(3):208-10. PubMed ID: 16706939
[TBL] [Abstract][Full Text] [Related]
57. Chronic myelogenous leukaemia (CML): an update.
Kumar L
Natl Med J India; 2006; 19(5):255-63. PubMed ID: 17203680
[TBL] [Abstract][Full Text] [Related]
58. Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.
Jadoul M; Piessevaux H; Ferrant A; Cosyns JP; van Ypersele de Strihou C
Nephrol Dial Transplant; 1995; 10(1):111-3. PubMed ID: 7724004
[No Abstract] [Full Text] [Related]
59. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
[TBL] [Abstract][Full Text] [Related]
60. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
